MetadataShow full item record
DescriptionNews release announcing that researchers at the University of Maryland School of Medicine (UMSOM) have begun testing an experimental stem cell therapy developed by Mesoblast Limited to treat hospitalized COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS) who are on ventilators to help them breathe. Additional information available via the accompanying video.
KeywordCoronavirus Disease 2019 (COVID-19)
University of Maryland, Baltimore
University of Maryland Medical Center
Stem Cell Research